Frankfurt - Delayed Quote EUR
Fate Therapeutics, Inc. (F6T.F)
1.0620
+0.0175
+(1.68%)
As of 8:12:25 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-123,333
-122,874
-132,263
-248,208
-162,870
Investing Cash Flow
37,577
12,218
112,665
166,751
-324,023
Financing Cash Flow
4,404
99,892
85
9,207
453,129
End Cash Position
55,147
46,283
57,047
76,560
148,810
Interest Paid Supplemental Data
--
--
--
--
0
Capital Expenditure
-1,840
-730
-6,153
-35,566
-50,704
Issuance of Capital Stock
-662
74,531
0
0
411,735
Repayment of Debt
--
--
--
--
0
Free Cash Flow
-125,173
-123,604
-138,416
-283,774
-213,574
12/31/2021 - 10/3/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade